ReviewNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2026
Neuropsychiatric illness in the later years of life: summary and synthesis.
Review in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dealing with neuropsychiatric illness in the later years of life is an immersion in complexity, born of heterogeneity in etiology, pathogenesis, clinical presentation, and response to intervention. We offer here a conceptual summary and synthesis of the key theme of heterogeneity, as embodied in the 20 papers that constitute this issue of Neuropsychopharmacology Reviews (NPPR's). We conclude with future scientific directions and moral imperatives for research and practice, already underway in many instances, but gaining in speed and transformative potential (especially in generative Artificial Intelligence and Large Language Models). We seek to review and to encourage research that works toward practical wisdom-- what Aristotle termed "phronesis," for promotion of resilience and wellbeing in older adults both at the individual and population levels.
Identifiers
41667638What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.